Figure 5A shows the ongoing monitoring of a single pancreatic cancer patient that indicates the detection of a KRAS mutation in the third longitudinal blood draw. Figure 5B shows an overview of a second patient with colorectal cancer. This evidence concerns the gene KRAS and pancreatic neoplasm.